Tennessee SB 2499: TennCare - As introduced, requires a managed care organization or pharmacy benefits manager that is contracted with the bureau to reimburse a claim for a long-acting injectable drug intended for treatment and prevention of human immunodeficiency virus and administered in a pharmacy, physician's office, clinic, ambulatory surgical treatment center, or hospital. - Amends TCA Title 4; Title 56 and Title 71.

Status: Assigned to General Subcommittee of Senate Commerce and Labor Committee (as of 2026-03-10)

State: Tennessee · Session: 114 · Bill: SB 2499

Subjects: TennCare

Sponsors: Kyle

View Tennessee SB 2499 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.